In April, the S&P/ASX 200 Index increased by 2.2 percent and was resilient to the uncertainty in the world market. Nevertheless, various key stocks plummeted drastically at the same time.
Investors experienced sharp declines in the selected businesses in retail, dairy, packaging, and health care industries. These decreases are between 21% and 44% over a month.
Poor trading news, a change of leadership, and geopolitical turmoil were followed by market responses. This paper looks at the events, the reasons these stocks declined, and the implications for investors.
The discussion identifies major factors that have led to the downturn and whether these declines are indicative of more structural problems or are temporary.
ASX 200 underperformers show sharp April declines amid market volatility. [Courtesy: The Economic Times]
Why Did ASX 200’s Worst Stocks in April 2026 Underperform Despite Market Gains?
The wider ASX 200 index was up 2.2 percent in April, which represented general investor confidence. However, this trend was not applied to all stocks. Some companies experienced firm-related issues that were stronger than the macroeconomic stability.
Poor profit outlook, operational issues, and a change of leadership became the causes of investor pessimism. Geopolitical tensions, in certain instances, further strained businesses in the world.
The dislocation underscores the fact that the performance of individual stocks tends to be based on internal fundamentals as opposed to overall index dynamics. Bad news was met with a prompt response by investors who practiced massive selling.
These drops highlight the significance of tracking company-related risks as well as macroeconomic trends. These sharp movements are also indications of the sensitivity of the market to earnings revisions.
How Did Temple & Webster Perform In April 2026?
Temple & Webster Group Ltd experienced a significant decrease in April. The stock dropped from $7.10 on 31 March to $5.64 on 30 April. This is a 20.6% monthly contraction.
The decline was sudden and due to a change of leadership. Mark Coulter, the CEO, resigned to take up the position of executive chair. Susie Sugden is set to become the new CEO as of 1 July.
The announcement caused a fall of 8.2% on 23 April alone. Investors tend to respond with caution to a change of leadership as they are not certain of the change of strategy.
The market sentiment became negative despite the market being well-positioned online in terms of furniture. The change of leadership raised issues of continuity of execution and the short-term performance perspective.
Temple & Webster shares fall after CEO transition announcement. [Courtesy: YouTube]
What Triggered The Fall In A2 Milk Shares?
Another company that underperformed significantly in April was A2 Milk Company Ltd. On 30 April, the shares closed at $7.08, which is a 26.0 percent drop. The recession came after a dismal trading announcement issued on 13 April. The stock dropped 13.0% on that day.
The management had noted a serious supply chain disruption to operations. Such uncertainties compelled us to lower FY 2026 profit projections. The growth in the revenues was also re-evaluated at a lower rate. EBITDA margin guidance dropped to 14.0%–14.5% from 15.5%–16.0%.
The lower profitability outlook was met with a strong response by investors. The downgrade created the issue of the efficiency of operations and the risk of dependence. The firm is now under pressure to stabilise the supply chains and win investor confidence back.
Why Did Orora Shares Decline Sharply In April?
Orora Ltd had one of the sharpest falls in the stock market (ASX 200). Shares fell to $1.31 by 30 April, down 30.7% for the month. The main catalyst was a trading update, which was published on 9 April.
On that one day, the share went down by 18.0%. The company revised FY 2026 EBIT estimates of its Saverglass division. New expectations lie between 63 million and 60 million euros. This is much less than the previous guidance of 79 million euros.
The downgrade is an expression of the turmoil associated with the Middle East conflict conditions. These are external forces that affect operations and demand. Investors reacted swiftly, and this was an indication of global exposure risks and the stability of earnings.
Orora share price falls after Saverglass earnings downgrade. [Courtesy: Print21]
How Did Cochlear Become The Worst Performer In April?
Cochlear Ltd was the most depreciating stock in the mentioned stocks. Shares closed at $94.00 on 30 April, down 44.4% for the month. The steep decline came after a poor trade update on 22 April.
The shares plummeted by 40.7 per cent on the day. The company mentioned the decline in demand in developed markets. Also, Middle Eastern market orders were cancelled because of the Iran war.
Cochlear revised its profit outlook for FY 2026. The new range is between $290 million and 330 million. This is a reduced figure of the previous 435 million to 460 million. The downgrade caused a robust negative investor sentiment.
ASX 200 Worst Stocks April 2026 Snapshot
April pointed to the underperformance of select ASX 200 stocks when the market was performing well, due to poor updates and external pressures:
- Temple and Webster Group Ltd fell by 20.6 per cent due to concerns over the change of the CEO.
- A2 Milk Company Ltd fell by 26.0% after the downgraded FY 2026 guidance.
- Orora Ltd dropped 30.7 percent following a reduction in Saverglass EBIT outlook.
- Cochlear Ltd plunged 44.4% due to weaker demand and a profit downgrade
What Do These Declines Mean For Investors?
The big drops underscore the dangers of holding non-performers in turbulent times. The performance of the company tends to prevail over the market performance.
Earnings guidance, operational updates, and geopolitical exposure are aspects that investors need to keep a close watch on.
Diversification is still important in dealing with such risks. These instances indicate the speed at which the sentiment can change in the wake of negative announcements.
Although the declines can be seen as a buying opportunity in some cases, some declines can also indicate more structural problems. The investors have to evaluate both short-term and long-term difficulties.
Investment decisions must be made with great caution after putting fundamentals into consideration. The April decline is a wake-up call that not everything on the index tends to move in line with the market trends.
Should Investors Consider Buying The Dip Now?
It is tempting to purchase the dip, but it has to be scrutinized. Not every falling stock is regained in a short time. Investors should consider the causes of each fall. Short-term disturbances can provide recovery possibilities.
But structural problems may result in long-term ineffectiveness. As an illustration, geopolitical risks and supply chain issues can continue to pose a risk.
Uncertainty in execution can also happen as a result of leadership transitions. Shareholders ought to look at revised instructions and prospectuses reports.
Additional information can be obtained with the help of external analyst recommendations and the opinions of the experts. Value traps are avoided by a disciplined approach. Such decisions are critical in terms of timing and risk tolerance.
Also Read: Viva Energy Rides Government Support to Fresh Gains on the ASX 200
FAQs
Q1. Which ASX 200 stocks performed the worst in April 2026?
A1: Temple & Webster, A2 Milk, Orora, and Cochlear declined 20.6%, 26.0%, 30.7%, and 44.4%, respectively.
Q2. Why did Cochlear shares fall the most?
A2: Cochlear cut profit guidance to $290–$330 million from $435–$460 million, triggering a 44.4% monthly drop.
Q3. What caused A2 Milk’s decline?
A3: Supply chain disruptions led to reduced FY 2026 guidance and EBITDA margins of 14.0%–14.5%.
Q4. Did the ASX 200 fall in April?
A4: No, the ASX 200 rose 2.2%, but individual stocks still recorded sharp declines.
Disclaimer:
This article is for informational purposes only and does not constitute financial advice. Stock market investments carry risks, including capital loss. The analysis is based on publicly available data and recent company updates. Investors should conduct independent research or consult a licensed financial advisor before making investment decisions related to ASX-listed companies.
Source Links:
- https://www.fool.com.au/2026/05/02/the-worst-4-asx-200-stocks-to-buy-and-hold-in-april-unmasked/
- https://www.ororagroup.com/
- https://www.templeandwebstergroup.com.au/Investor-Centre/
